KR101777561B1 - N-메틸-4-벤질카브아미도피리디늄 클로라이드 및 이의 제조방법 - Google Patents

N-메틸-4-벤질카브아미도피리디늄 클로라이드 및 이의 제조방법 Download PDF

Info

Publication number
KR101777561B1
KR101777561B1 KR1020147028207A KR20147028207A KR101777561B1 KR 101777561 B1 KR101777561 B1 KR 101777561B1 KR 1020147028207 A KR1020147028207 A KR 1020147028207A KR 20147028207 A KR20147028207 A KR 20147028207A KR 101777561 B1 KR101777561 B1 KR 101777561B1
Authority
KR
South Korea
Prior art keywords
methyl
chloride
chloromethane
isonicotinic acid
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020147028207A
Other languages
English (en)
Korean (ko)
Other versions
KR20150013124A (ko
Inventor
필리야 체브로브스카
그리고리 코스티우크
미카일로 바나트
빅토르 마지티크
Original Assignee
팔마크 인터내셔널 홀딩 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 팔마크 인터내셔널 홀딩 게엠베하 filed Critical 팔마크 인터내셔널 홀딩 게엠베하
Publication of KR20150013124A publication Critical patent/KR20150013124A/ko
Application granted granted Critical
Publication of KR101777561B1 publication Critical patent/KR101777561B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020147028207A 2012-05-18 2013-05-16 N-메틸-4-벤질카브아미도피리디늄 클로라이드 및 이의 제조방법 Expired - Fee Related KR101777561B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2012/059258 2012-05-18
PCT/EP2012/059258 WO2013170901A1 (en) 2012-05-18 2012-05-18 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation
PCT/EP2013/060158 WO2013171307A1 (en) 2012-05-18 2013-05-16 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation

Publications (2)

Publication Number Publication Date
KR20150013124A KR20150013124A (ko) 2015-02-04
KR101777561B1 true KR101777561B1 (ko) 2017-09-12

Family

ID=48483057

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147028207A Expired - Fee Related KR101777561B1 (ko) 2012-05-18 2013-05-16 N-메틸-4-벤질카브아미도피리디늄 클로라이드 및 이의 제조방법

Country Status (12)

Country Link
US (2) US9493416B2 (enExample)
EP (1) EP2850063B1 (enExample)
JP (1) JP2015517513A (enExample)
KR (1) KR101777561B1 (enExample)
BR (1) BR112014028576B1 (enExample)
CA (1) CA2873977C (enExample)
EA (1) EA025409B1 (enExample)
ES (1) ES2573286T3 (enExample)
IN (1) IN2014DN10683A (enExample)
PL (1) PL2850063T3 (enExample)
UA (1) UA110889C2 (enExample)
WO (2) WO2013170901A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2689775C1 (ru) * 2018-11-02 2019-05-29 Открытое акционерное общество "Авексима" Способ промышленного производства N-метил-4-бензилкарбамидопиридиния йодида

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011157743A1 (en) 2010-06-17 2011-12-22 Farmak International Holding Gmbh Alpha-crystalline form of carbabenzpyride

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU58612A1 (ru) 1939-10-29 1939-11-30 П.С. Мордовин Устройство дл включени в одну станционную линию двухабонентских аппаратов
SU548612A1 (ru) 1975-07-18 1977-02-28 Казанский Химико-Технологический Институт Им.С.М.Кирова Способ получени 10-хлорфеноксарсина
US4115390A (en) * 1977-08-19 1978-09-19 Nardi John C Method for the preparation of 1-alkyl pyridinium chlorides
ATE178320T1 (de) * 1992-06-04 1999-04-15 Micro Flo Co Mepiquat chloride

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011157743A1 (en) 2010-06-17 2011-12-22 Farmak International Holding Gmbh Alpha-crystalline form of carbabenzpyride

Also Published As

Publication number Publication date
BR112014028576A2 (pt) 2017-06-27
JP2015517513A (ja) 2015-06-22
US20170037011A1 (en) 2017-02-09
CN104321312A (zh) 2015-01-28
CA2873977A1 (en) 2013-11-21
KR20150013124A (ko) 2015-02-04
EP2850063A1 (en) 2015-03-25
UA110889C2 (uk) 2016-02-25
BR112014028576B1 (pt) 2020-11-03
EP2850063B1 (en) 2016-04-13
PL2850063T3 (pl) 2016-10-31
US9493416B2 (en) 2016-11-15
US20140357677A1 (en) 2014-12-04
CA2873977C (en) 2019-09-17
WO2013170901A1 (en) 2013-11-21
EA201492161A1 (ru) 2015-03-31
ES2573286T3 (es) 2016-06-07
WO2013171307A1 (en) 2013-11-21
IN2014DN10683A (enExample) 2015-08-28
EA025409B1 (ru) 2016-12-30

Similar Documents

Publication Publication Date Title
CN111448189A (zh) 一种联芳基衍生物、其制备方法和在药学上的应用
WO2017028751A1 (zh) L-bpa的制备方法
AU2019230497A1 (en) Crystal form and salt form of pyridoimidazole compound and preparation method therefor
CN108947949B (zh) 抗焦虑氘代化合物及其医药用途
CN115260167A (zh) 一种3-四唑基甲基-1,3,5-三嗪-2,4-二酮类化合物及其制备方法和应用
KR101777561B1 (ko) N-메틸-4-벤질카브아미도피리디늄 클로라이드 및 이의 제조방법
CN104185633B (zh) 扎托布洛芬及其衍生物的制造方法
CN106939002B (zh) 一种btk激酶抑制剂的结晶形式及其制备方法
JP2018503608A (ja) 塩酸ヨンケナフィルの多形体及びその調製方法、組成物並びに用途
EP2851363B1 (en) Agomelatine acid radical composite, and preparation method and application thereof
CN106967064A (zh) 氘代Palbociclib的衍生物、制备方法及其应用
CN110054616A (zh) 三嗪类idh抑制剂的制备方法
WO2011158058A1 (en) α-CRYSTALLINE FORM OF CARBABENZPYRIDE
WO2018223970A1 (zh) 一种艾司西酞普兰双羟萘酸盐新的制备方法
EP2621891B1 (en) Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
WO2018214877A1 (zh) 一种地佐辛晶型及其制备方法
CN108299479A (zh) F-bpa的制备方法
CN108409754B (zh) 依度沙班氧化降解杂质的制备方法及用途
CA3137209C (en) Crystalline form of compound, method for preparing the same, pharmaceutical composition and use
US11014885B2 (en) Method for preparing donepezil pamoate
KR101544758B1 (ko) (오쏘-카보란-1-일)알콕시-1,3,5-트리아진 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물
CN103553959B (zh) 用l-焦谷氨酸和无水乙胺合成l-茶氨酸的方法
DE1445453C (de) s-Triazolo eckige Klammer auf 4, 3,-2,3 eckige Klammer zu -as-triazino eckige Klammer auf 5,6-b eckige Klammer zu indole, Verfahren zu ihrer Herstellung und Arzneimittel
KR20080015209A (ko) 오르토-카르보란-1-일-1,3,5-트리아진 유도체, 이의제조방법 및 이를 포함하는 약학적 조성물
CA3137209A1 (en) Crystalline form of compound, method for preparing the same, pharmaceutical composition and use

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20210907

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20210907